BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 16615017)

  • 21. [One-year follow up results of Smoking Cessation Outpatient Clinic].
    Demir T; Tutluoğlu B; Koç N; Bilgin L
    Tuberk Toraks; 2004; 52(1):63-8. PubMed ID: 15143375
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Randomized trial of an intervention to facilitate recycling for relapsed smokers.
    Partin MR; An LC; Nelson DB; Nugent S; Snyder A; Fu SS; Willenbring ML; Joseph AM
    Am J Prev Med; 2006 Oct; 31(4):293-9. PubMed ID: 16979453
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [The importance of the at risk COPD patients (Stage 0) and clinical differences].
    Kömüs N; Tertemiz KC; Sevinç C
    Tuberk Toraks; 2008; 56(4):382-9. PubMed ID: 19123073
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Lung function testing influences the attitude toward smoking cessation.
    Sundblad BM; Larsson K; Nathell L
    Nicotine Tob Res; 2010 Jan; 12(1):37-42. PubMed ID: 19926685
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Characteristics of outpatients with COPD in daily practice: The E4 Spanish project.
    Viejo-Bañuelos JL; Pueyo-Bastida A; Fueyo-Rodríguez A
    Respir Med; 2006 Dec; 100(12):2137-43. PubMed ID: 16831541
    [TBL] [Abstract][Full Text] [Related]  

  • 26. General practice counseling for patients with chronic obstructive pulmonary disease to quit smoking: impact after 1 year of two complex interventions.
    Hilberink SR; Jacobs JE; Breteler MH; de Vries H; Grol RP
    Patient Educ Couns; 2011 Apr; 83(1):120-4. PubMed ID: 20430565
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Smoking cessation and the course of Crohn's disease: an intervention study.
    Cosnes J; Beaugerie L; Carbonnel F; Gendre JP
    Gastroenterology; 2001 Apr; 120(5):1093-9. PubMed ID: 11266373
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Implementing a hospital-based smoking cessation programme: evidence for a learning effect.
    Raupach T; Shahab L; Neubert K; Felten D; Hasenfuss G; Andreas S
    Patient Educ Couns; 2008 Feb; 70(2):199-204. PubMed ID: 18031972
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Differences in responses upon corticosteroid therapy between smoking and non-smoking patients with COPD.
    Van Overveld FJ; Demkow U; Górecka D; De Backer WA; Zieliński J
    J Physiol Pharmacol; 2006 Sep; 57 Suppl 4():273-82. PubMed ID: 17072055
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Smoking cessation--but not smoking reduction--improves the annual decline in FEV1 in occupationally exposed workers.
    Bohadana AB; Nilsson F; Westin A; Martinet N; Martinet Y
    Respir Med; 2006 Aug; 100(8):1423-30. PubMed ID: 16356702
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A randomized trial of smoking cessation. Medication versus motivation.
    Uyar M; Filiz A; Bayram N; Elbek O; Herken H; Topcu A; Dikensoy O; Ekinci E
    Saudi Med J; 2007 Jun; 28(6):922-6. PubMed ID: 17530112
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Nutritional risk factors for the development of chronic obstructive pulmonary disease (COPD) in male smokers.
    Celik F; Topcu F
    Clin Nutr; 2006 Dec; 25(6):955-61. PubMed ID: 16782241
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A novel polymorphism in CDC6 is associated with the decline in lung function of ex-smokers in COPD.
    Takabatake N; Toriyama S; Igarashi A; Tokairin Y; Takeishi Y; Konta T; Inoue S; Abe S; Shibata Y; Kubota I
    Biochem Biophys Res Commun; 2009 Apr; 381(4):554-9. PubMed ID: 19233139
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Influence of smoking cessation on airway T lymphocyte subsets in COPD.
    Roos-Engstrand E; Ekstrand-Hammarström B; Pourazar J; Behndig AF; Bucht A; Blomberg A
    COPD; 2009 Apr; 6(2):112-20. PubMed ID: 19378224
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Evaluation of patients followed up in a cigarette cessation clinic.
    Akkaya A; Oztürk O; Cobanoğlu H; Bircan HA; Simşek S; Sahin U
    Respirology; 2006 May; 11(3):311-6. PubMed ID: 16635090
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A 12-week double-blind, placebo-controlled study of bupropion sr added to high-dose dual nicotine replacement therapy for smoking cessation or reduction in schizophrenia.
    Evins AE; Cather C; Culhane MA; Birnbaum A; Horowitz J; Hsieh E; Freudenreich O; Henderson DC; Schoenfeld DA; Rigotti NA; Goff DC
    J Clin Psychopharmacol; 2007 Aug; 27(4):380-6. PubMed ID: 17632223
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A smoking ban in public places increases the efficacy of bupropion and counseling on cessation outcomes at 1 year.
    Grassi MC; Enea D; Ferketich AK; Lu B; Nencini P
    Nicotine Tob Res; 2009 Sep; 11(9):1114-21. PubMed ID: 19654237
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Smoking reduction and the rate of decline in FEV(1): results from the Lung Health Study.
    Simmons MS; Connett JE; Nides MA; Lindgren PG; Kleerup EC; Murray RP; Bjornson WM; Tashkin DP
    Eur Respir J; 2005 Jun; 25(6):1011-7. PubMed ID: 15929955
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Principles of confrontational counselling in smokers with chronic obstructive pulmonary disease (COPD).
    Kotz D; Huibers MJ; Vos R; van Schayck CP; Wesseling G
    Med Hypotheses; 2008; 70(2):384-6. PubMed ID: 17604568
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Smoking cessation treatment in a real-life setting: the Greek experience.
    Rovina N; Nikoloutsou I; Dima E; Michailidou M; Roussos C; Gratziou C
    Ther Adv Respir Dis; 2007 Dec; 1(2):93-104. PubMed ID: 19124351
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.